Spinal Muscular Atrophy STAT Panel (SPONSORED) Test code: 73000 • 4 calendar days

Spinal Muscular Atrophy STAT Panel (SPONSORED) Test code: 73000 • 4 calendar days
$0.00

Test Description

The Fact DNA Spinal Muscular Atrophy (SMA) STAT Genetic Test evaluates the copy number of the SMN1 gene, which is associated with spinal muscular atrophy (SMA). SMA is an inherited neuromuscular condition that affects motor neurons in the spinal cord and may lead to progressive muscle weakness and muscle atrophy.

When a homozygous deletion of SMN1 is identified, the test also reports the SMN2 copy number. The number of SMN2 copies can provide additional information that may help healthcare professionals assess the potential severity of SMN1-related SMA.

What the Test Evaluates

  • SMN1 copy number to identify deletions associated with SMA
  • SMN2 copy number, when applicable, to provide additional information regarding potential disease severity
  • Genetic findings that may assist healthcare professionals in evaluating suspected or confirmed SMA

Important: This test evaluates SMN1 copy number and does not detect all SMN1 sequence variants. Additional genetic testing may be recommended when clinically appropriate.

Rapid STAT Testing

This test offers an accelerated turnaround time of approximately 4 days, which may be valuable when rapid genetic information is needed to support time-sensitive clinical evaluation and healthcare decisions.

Early identification of SMA can be important because disease progression may begin early in life. Genetic testing may provide information that helps healthcare professionals determine appropriate next steps, including evaluation of available treatment options and consideration of emerging therapies when appropriate.

Why Early Genetic Testing Matters

Identifying an underlying genetic change associated with SMA can provide valuable information for patients, families, and healthcare professionals. Results may help support clinical evaluation, treatment planning, genetic counseling, and informed family-planning decisions.

Genetic testing should be ordered and interpreted by a qualified healthcare professional. Results should be considered together with the patient's medical history, family history, and clinical findings. A genetic test does not independently determine disease severity or guarantee response to any particular treatment.